Rodgers, James D.,Shepard, Stacey,Arvanitis, Argyrios G.,Wang, Haisheng,Storace, Louis,Folmer, Beverly,Shao, Lixin,Zhu, Wenyu,Glenn, Joseph P.
申请号:
AU2010249380
公开号:
AU2010249380B2
申请日:
2010.05.21
申请国别(地区):
AU
年份:
2015
代理人:
摘要:
The present invention relates to N-(hetero)aryl-pyrrolidine derivatives of Formula (I): which are JAK inhibitors, such as selective JAK1 inhibitors, useful in the treatment of JAK-associated diseases including, for example, inflammatory and autoimmune disorders, as well as cancer.